VasGene Therapeutics (United States)

Recent papers from VasGene Therapeutics (United States)

1. Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancerExperimental and Molecular Pathology · 2026
2. Association of ephrinB2 (B2) expression on overall survival (OS) and resistance to PD1/L1 inhibitors (inh) in metastatic urothelial carcinoma (mUC).Journal of Clinical Oncology · 2024
3. Evaluation of the effect of erenumab on migraine‐specific questionnaire in patients with chronic and episodic migraineCPT Pharmacometrics & Systems Pharmacology · 2023
4. Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic CancerCancers · 2021
5. EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKTBlood Advances · 2017
6. EphB4/EphrinB2 therapeutics in RhabdomyosarcomaPLoS ONE · 2017
7. Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell CarcinomasScientific Reports · 2016
8. Ephrin‐B2 overexpression predicts for poor prognosis and response to therapy in solid tumorsMolecular Carcinogenesis · 2016
9. Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinomaBritish Journal of Cancer · 2015
10. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159Journal of Nuclear Medicine · 2015
11. The Differential Expression of EphB2 and EphB4 Receptor Kinases in Normal Bladder and in Transitional Cell Carcinoma of the BladderPLoS ONE · 2014
12. Design, Synthesis, and Validation of Axl-Targeted Monoclonal Antibody Probe for microPET Imaging in Human Lung Cancer XenograftMolecular Pharmaceutics · 2014
13. EphB4-Targeted Imaging with Antibody h131, h131-F(ab′)2 and h131-FabMolecular Pharmaceutics · 2013
14. Monoclonal Antibody against Cell Surface GRP78 as a Novel Agent in Suppressing PI3K/AKT Signaling, Tumor Growth, and MetastasisClinical Cancer Research · 2013
15. The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic TargetPLoS ONE · 2013
16. EphB4 as a therapeutic target in mesotheliomaBMC Cancer · 2013
17. PET Imaging of Colorectal and Breast Cancer by Targeting EphB4 Receptor with64Cu-Labeled hAb47 and hAb131 AntibodiesJournal of Nuclear Medicine · 2013
18. Targeting the EphB4 Receptor for Cancer Diagnosis and Therapy MonitoringMolecular Pharmaceutics · 2012
19. Immunotherapy with autologous tumor cell vaccines for treatment of occult disease in early stage colon cancerHuman Vaccines & Immunotherapeutics · 2012
20. Low-Dosage Inhibition of Dll4 Signaling Promotes Wound Healing by Inducing Functional Neo-AngiogenesisPLoS ONE · 2012